Fertility preservation in female cancer patients

References

• Edwards BK, Brown ML, Wingo PA et al. Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. J. Natl Cancer Inst.97(19), 1407–1427 (2005).
   PubMed Web of Science ®Google Scholar
• Jemal A, Clegg LX, Ward E et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer101(1), 3–27 (2004).
   PubMed Web of Science ®Google Scholar
• Bath LE, Wallace WH, Critchley HO. Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. Br. J. Gynaecol.109(2), 107–114 (2002).
   Google Scholar
• Simon B, Lee SJ, Partridge AH, Runowicz CD. Preserving fertility after cancer. Cancer J. Clin.55(4), 211–228 (2005).
   PubMed Web of Science ®Google Scholar
• Garner E, Goldstein DP, Berkowitz RS, Wenzel L. Psychosocial and reproductive outcomes of gestational trophoblastic diseases. Best Pract. Res. Clin. Obstet. Gynaecol.17(6), 959–968 (2003).
   Google Scholar
• Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature428(6979), 145–150 (2004).
   PubMed Web of Science ®Google Scholar
• Forbasco AS, de Pol A, Vizzotto L, Marzona L. Morphometric study of the human neonatal ovary. Anat. Rec.231, 201–208 (1991).
   Google Scholar
• Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum. Reprod.7(10), 1342–1346 (1992).
   PubMed Web of Science ®Google Scholar
• Hensley ML, Reichman BS. Fertility and pregnancy after adjuvant chemotherapy for breast cancer. Crit. Rev. Oncol. Hematol.28(2), 121–128 (1998).
   PubMed Web of Science ®Google Scholar
• Wallace WH, Blacklay A, Eiser C et al. Developing strategies for long term follow up of survivors of childhood cancer. Br. Med. J.323(7307), 271–274 (2001).
   PubMed Web of Science ®Google Scholar
• Thomson AB, Critchley HO, Wallace WH. Fertility and progeny. Eur. J. Cancer38(12), 1634–1644 (2002).
   Google Scholar
• Damewood MD, Grochow LB. Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertil. Steril.45(4), 443–459 (1986).
   PubMed Web of Science ®Google Scholar
• Meirow D, Epstein M, Lewis H, Nugent D, Gosden RG. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum. Reprod.16(4), 632–637 (2001).
   PubMed Web of Science ®Google Scholar
• Warne GL, Fairley KF, Hobbs JB, Martin FI. Cyclophosphamide-induced ovarian failure. N. Engl. J. Med.289(22), 1159–1162 (1973).
   PubMed Web of Science ®Google Scholar
• Koyama H, Wada T, Nishizawa Y, Iwanaga T, Aoki Y. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer39(4), 1403–1409 (1977).
   PubMed Web of Science ®Google Scholar
• Familiari G, Caggiati A, Nottola SA, Ermini M, Di Benedetto MR, Motta PM. Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum. Reprod.8(12), 2080–2087 (1993).
   PubMed Web of Science ®Google Scholar
• Lobo RA. Potential options for preservation of fertility in women. N. Engl. J. Med.353(1), 64–73 (2005).
   PubMed Web of Science ®Google Scholar
• Chapman RM, Sutcliffe SB, Malpas JS. Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function. JAMA242(17), 1877–1881 (1979).
   PubMed Web of Science ®Google Scholar
• Couto-Silva AC, Trivin C, Thibaud E, Esperou H, Michon J, Brauner R. Factors affecting gonadal function after bone marrow transplantation during childhood. Bone Marrow Transplant.28(1), 67–75 (2001).
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Kanda Y, Yamashita H et al. Preservation of ovarian function by ovarian shielding when undergoing total body irradiation for hematopoietic stem cell transplantation: a report of two successful cases. Bone Marrow Transplant.37(6), 583–587 (2006).
   PubMed Web of Science ®Google Scholar
• Stovall M, Donaldson SS, Weathers RE et al. Genetic effects of radiotherapy for childhood cancer: gonadal dose reconstruction. Int. J. Radiat. Oncol. Biol. Phys.60(2), 542–552 (2004).
   PubMed Web of Science ®Google Scholar
• Byrne J, Mulvihill JJ, Myers MH et al. Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. N. Engl. J. Med.317(21), 1315–1321 (1987).
   PubMed Web of Science ®Google Scholar
• Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum. Reprod.18(1), 117–121 (2003).
   PubMed Web of Science ®Google Scholar
• Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int. J. Radiat. Oncol. Biol. Phys.62(3), 738–744 (2005).
   PubMed Web of Science ®Google Scholar
• Critchley HO, Wallace WH. Impact of cancer treatment on uterine function. J. Natl Cancer Inst. Monogr. (34), 64–68 (2005).
   Google Scholar
• Holm K, Nysom K, Brocks V, Hertz H, Jacobsen N, Muller J. Ultrasound B-mode changes in the uterus and ovaries and Doppler changes in the uterus after total body irradiation and allogeneic bone marrow transplantation in childhood. Bone Marrow Transplant.23(3), 259–263 (1999).
   PubMed Web of Science ®Google Scholar
• Bath LE, Critchley HO, Chambers SE, Anderson RA, Kelnar CJ, Wallace WH. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Br. J. Obstet. Gynaecol.106(12), 1265–1272 (1999).
   PubMedGoogle Scholar
• Larsen EC, Schmiegelow K, Rechnitzer C, Loft A, Muller J, Andersen AN. Radiotherapy at a young age reduces uterine volume of childhood cancer survivors. Acta Obstet. Gynecol. Scand.83(1), 96–102 (2004).
   PubMed Web of Science ®Google Scholar
• Chiarelli AM, Marrett LD, Darlington G. Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964–1988 in Ontario, Canada. Am. J. Epidemiol.150(3), 245–254 (1999).
   Google Scholar
• Hawkins MM, Smith RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int. J. Cancer43(3), 399–402 (1989).
   PubMed Web of Science ®Google Scholar
• Li FP, Fine W, Jaffe N, Holmes GE, Holmes FF. Offspring of patients treated for cancer in childhood. J. Natl Cancer Inst.62(5), 1193–1197 (1979).
   PubMed Web of Science ®Google Scholar
• Byrne J, Rasmussen SA, Steinhorn SC et al. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am. J. Hum. Genet.62(1), 45–52 (1998).
   PubMed Web of Science ®Google Scholar
• Green DM, Zevon MA, Lowrie G, Seigelstein N, Hall B. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. N. Engl. J. Med.325(3), 141–146 (1991).
   PubMed Web of Science ®Google Scholar
• Nagarajan R, Robison LL. Pregnancy outcomes in survivors of childhood cancer. J. Natl Cancer Inst. Monogr. (34), 72–76 (2005).
   Google Scholar
• Ginsburg ES, Yanushpolsky EH, Jackson KV. In vitro fertilization for cancer patients and survivors. Fertil. Steril.75(4), 705–710 (2001).
   PubMed Web of Science ®Google Scholar
• Kim SS. Fertility preservation in female cancer patients: current developments and future directions. Fertil. Steril.85(1), 1–11 (2006).
   PubMed Web of Science ®Google Scholar
• Blakely LJ, Buzdar AU, Lozada JA et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer100(3), 465–469 (2004).
   PubMed Web of Science ®Google Scholar
• Van der Elst J. Oocyte freezing: here to stay? Hum. Reprod. Update9(5), 463–470 (2003).
   PubMed Web of Science ®Google Scholar
• Borini A, Bonu MA, Coticchio G, Bianchi V, Cattoli M, Flamigni C. Pregnancies and births after oocyte cryopreservation. Fertil. Steril.82(3), 601–605 (2004).
   Google Scholar
• Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil. Steril.86(1), 70–80 (2006).
   PubMed Web of Science ®Google Scholar
• Boldt J, Tidswell N, Sayers A, Kilani R, Cline D. Human oocyte cryopreservation: 5-year experience with a sodium-depleted slow freezing method. Reprod. Biomed. Online13(1), 96–100 (2006).
   PubMedGoogle Scholar
• Tucker MJ, Wright G, Morton PC, Massey JB. Birth after cryopreservation of immature oocytes with subsequent in vitro maturation. Fertil. Steril.70(3), 578–579 (1998).
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine. Ovarian tissue and oocyte cryopreservation. Fertil. Steril.82(4), 993–998 (2004).
   PubMedGoogle Scholar
• Oktay K, Economos K, Kan M, Rucinski J, Veeck L, Rosenwaks Z. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA286(12), 1490–1493 (2001).
   PubMed Web of Science ®Google Scholar
• Almodin CG, Minguetti-Camara VC, Meister H et al. Recovery of fertility after grafting of cryopreserved germinative tissue in female rabbits following radiotherapy. Hum. Reprod.19(6), 1287–1293 (2004).
   Google Scholar
• Sonmezer M, Oktay K. Fertility preservation in female patients. Hum. Reprod. Update10(3), 251–266 (2004).
   PubMed Web of Science ®Google Scholar
• Oktay K, Buyuk E, Veeck L et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet363(9412), 837–840 (2004).
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM, Demylle D et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet364(9443), 1405–1410 (2004).
   PubMed Web of Science ®Google Scholar
• Oktay K, Tilly J. Livebirth after cryopreserved ovarian tissue autotransplantation. Lancet364(9451), 2091–2092 (2004).
   PubMedGoogle Scholar
• Meirow D, Levron J, Eldar-Geva T et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N. Engl. J. Med.353(3), 318–321 (2005).
   PubMed Web of Science ®Google Scholar
• Baird DT, Webb R, Campbell BK, Harkness LM, Gosden RG. Long-term ovarian function in sheep after ovariectomy and transplantation of autografts stored at -196 °C. Endocrinology140(1), 462–471 (1999).
   PubMed Web of Science ®Google Scholar
• Radford JA, Lieberman BA, Brison DR et al. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma. Lancet357(9263), 1172–1175 (2001).
   PubMed Web of Science ®Google Scholar
• Oktay K, Sonmezer M. Ovarian tissue banking for cancer patients: fertility preservation, not just ovarian cryopreservation. Hum. Reprod.19(3), 477–480 (2004).
   PubMed Web of Science ®Google Scholar
• Kim SS, Radford J, Harris M et al. Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation. Hum. Reprod.16(10), 2056–2060 (2001).
   PubMed Web of Science ®Google Scholar
• Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J. Clin. Oncol.23(19), 4347–4353 (2005).
   PubMed Web of Science ®Google Scholar
• Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J. Clin. Oncol.23(16), 3858–3859 (2005).
   PubMed Web of Science ®Google Scholar
• Biljan MM, Hemmings R, Brassard, N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil. Steril.84(Suppl. 1), S95 (2005).
   Web of Science ®Google Scholar
• Tulandi T, Martin J, Al-Fadhli R et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil. Steril.85(6), 1761–1765 (2006).
   PubMed Web of Science ®Google Scholar
• Janssens RM, Brus L, Cahill DJ, Huirne JA, Schoemaker J, Lambalk CB. Direct ovarian effects and safety aspects of GnRH agonists and antagonists. Hum. Reprod. Update6(5), 505–518 (2000).
   PubMed Web of Science ®Google Scholar
• Rabinovici J, Rothman P, Monroe SE, Nerenberg C, Jaffe RB. Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin-releasing hormone antagonist (Ganirelix) with minimal histamine-releasing properties: studies in postmenopausal women. J. Clin. Endocrinol. Metab.75(5), 1220–1225 (1992).
   PubMed Web of Science ®Google Scholar
• Tureck RW, Mastroianni L Jr, Blasco L, Strauss JF III. Inhibition of human granulosa cell progesterone secretion by a gonadotropin-releasing hormone agonist. J. Clin. Endocrinol. Metab.54(5), 1078–1080 (1982).
   Google Scholar
• Popkin R, Bramley TA, Currie A, Shaw RW, Baird DT, Fraser HM. Specific binding of luteinizing hormone releasing hormone to human luteal tissue. Biochem. Biophys. Res. Commun.114(2), 750–756 (1983).
   PubMed Web of Science ®Google Scholar
• Gunthert AR, Grundker C, Bottcher B, Emons G. Luteinizing hormone-releasing hormone (LHRH) inhibits apoptosis induced by cytotoxic agent and UV-light but not apoptosis mediated through CD95 in human ovarian and endometrial cancer cells. Anticancer Res.24(3a), 1727–1732 (2004).
   PubMed Web of Science ®Google Scholar
• Ataya K, Rao LV, Lawrence E, Kimmel R. Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol. Reprod.52(2), 365–372 (1995).
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z, Eckman A. Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a. J. Natl Cancer Inst. Monogr. (34), 40–43 (2005).
   Google Scholar
• Blumenfeld Z, Avivi I, Linn S, Epelbaum R, Ben-Shahar M, Haim N. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Hum. Reprod.11(8), 1620–1626 (1996).
   PubMed Web of Science ®Google Scholar
• Pereyra-Pacheco B, Mendez Ribas JM, Milone G et al. Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report. Gynecol. Oncol.81(3), 391–397 (2001).
   Google Scholar
• Dann EJ, Epelbaum R, Avivi I et al. Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma. Hum. Reprod.20(8), 2247–2249 (2005).
   PubMed Web of Science ®Google Scholar
• Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J. Clin. Oncol.14(5), 1718–1729 (1996).
   PubMed Web of Science ®Google Scholar
• Recchia F, Saggio G, Amiconi G et al. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer106(3), 514–523 (2006).
   PubMed Web of Science ®Google Scholar
• Del Mastro L, Catzeddu T, Boni L et al. Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann. Oncol.17(1), 74–78 (2006).
   PubMed Web of Science ®Google Scholar
• Waxman JH, Ahmed R, Smith D, et al. Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother. Pharmacol.19(2), 159–162 (1987).
   PubMed Web of Science ®Google Scholar
• Ataya K, Pydyn E, Ramahi-Ataya A, Orton CG. Is radiation-induced ovarian failure in rhesus monkeys preventable by luteinizing hormone-releasing hormone agonists?: preliminary observations. J. Clin. Endocrinol. Metab.80(3), 790–795 (1995).
   PubMed Web of Science ®Google Scholar
• Gosden RG, Wade JC, Fraser HM, Sandow J, Faddy MJ. Impact of congenital or experimental hypogonadotrophism on the radiation sensitivity of the mouse ovary. Hum. Reprod.12(11), 2483–2488 (1997).
   PubMed Web of Science ®Google Scholar
• Danforth DR, Arbogast LK, Friedman CI. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists. Fertil. Steril.83(5), 1333–1338 (2005).
   PubMed Web of Science ®Google Scholar
• Mardesic T, Snajderova M, Sramkova L, Keslova P, Sedlacek P, Stary J. Protocol combining GnRH agonists and GnRH antagonists for rapid suppression and prevention of gonadal damage during cytotoxic therapy. Eur. J. Gynaecol. Oncol.25(1), 90–92 (2004).
   PubMed Web of Science ®Google Scholar
• Jonat W, Kaufmann M, Sauerbrei W et al. Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: the Zoladex Early Breast Cancer Research Association Study. J. Clin. Oncol.20(24), 4628–4635 (2002).
   PubMed Web of Science ®Google Scholar
• Tilly JL, Kolesnick RN. Sphingolipids, apoptosis, cancer treatments and the ovary: investigating a crime against female fertility. Biochim. Biophys. Acta.1585(2–3), 135–138 (2002).
   PubMed Web of Science ®Google Scholar
• Morita Y, Perez GI, Paris F et al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat. Med.6(10), 1109–1114 (2000).
   PubMed Web of Science ®Google Scholar
• Perez GI, Jurisicova A, Matikainen T et al. A central role for ceramide in the age-related acceleration of apoptosis in the female germline. Faseb J.19(7), 860–862 (2005).
   PubMed Web of Science ®Google Scholar
• Tedesco-Silva H, Mourad G, Kahan BD et al. FTY720, a novel immunomodulator: efficacy and safety results from the first Phase 2A study in de novo renal transplantation. Transplantation79(11), 1553–1560 (2005).
   PubMed Web of Science ®Google Scholar
• Williams RS, Littell RD, Mendenhall NP. Laparoscopic oophoropexy and ovarian function in the treatment of Hodgkin disease. Cancer86(10), 2138–2142 (1999).
   PubMed Web of Science ®Google Scholar
• Morice P, Thiam-Ba R, Castaigne D et al. Fertility results after ovarian transposition for pelvic malignancies treated by external irradiation or brachytherapy. Hum. Reprod.13(3), 660–663 (1998).
   PubMed Web of Science ®Google Scholar
• Ray GR, Trueblood HW, Enright LP, Kaplan HS, Nelsen TS. Oophoropexy: a means of preserving ovarian function following pelvic megavoltage radiotherapy for Hodgkin's disease. Radiology96(1), 175–180 (1970).
   PubMed Web of Science ®Google Scholar
• Scott SM, Schlaff W. Laparoscopic medial oophoropexy prior to radiation therapy in an adolescent with Hodgkin's disease. J. Pediatr. Adolesc. Gynecol.18(5), 355–357 (2005).
   Google Scholar
• Hadar H, Loven D, Herskovitz P, Bairey O, Yagoda A, Levavi H. An evaluation of lateral and medial transposition of the ovaries out of radiation fields. Cancer74(2), 774–779 (1994).
   PubMedGoogle Scholar
• Covens AL, van der Putten HW, Fyles AW et al. Laparoscopic ovarian transposition. Eur. J. Gynaecol. Oncol.17(3), 177–182 (1996).
   Google Scholar
• Cowles RA, Gewanter RM, Kandel JJ. Ovarian repositioning in pediatric cancer patients: flexible techniques accommodate pelvic radiation fields. Pediatr. Blood CancerDOI: 10.1002/pbc.20652 (2006).
   Google Scholar
• Tulandi T, Al-Took S. Laparoscopic ovarian suspension before irradiation. Fertil. Steril.70(2), 381–383 (1998).
   PubMed Web of Science ®Google Scholar
• Le Floch O, Donaldson SS, Kaplan HS. Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin's disease. Cancer38(6), 2263–2268 (1976).
   PubMed Web of Science ®Google Scholar
• Thomas PR, Winstanly D, Peckham MJ, Austin DE, Murray MA, Jacobs HS. Reproductive and endocrine function in patients with Hodgkin's disease: effects of oophoropexy and irradiation. Br. J. Cancer33(2), 226–231 (1976).
   PubMed Web of Science ®Google Scholar
• Liou WS, Yap OW, Chan JK, Westphal LM. Innovations in fertility preservation for patients with gynecologic cancers. Fertil. Steril.84(6), 1561–1573 (2005).
   PubMedGoogle Scholar